You can buy or sell GENE and other stocks, options, ETFs, and crypto commission-free!
Genetic Technologies Ltd. engages in the provision of molecular risk assessment for cancer. It operates through the USA and Australia geographical segments. Read More Its product, BREVAGenplus, is a clinically validated risk assessment test for non-hereditary breast cancer. The company was founded on January 5, 1987 and is headquartered in Fitzroy, Australia.
Fitzroy, Victoria (VIC)
52 Week High
52 Week Low